QSELEQ Trademark

Trademark Overview

On Thursday, April 27, 2017, a trademark application was filed for QSELEQ with the United States Patent and Trademark Office. The USPTO has given the QSELEQ trademark a serial number of 79213430. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 21, 2024. This trademark is owned by Astellas Pharma Inc.. The QSELEQ trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
qseleq

General Information

Serial Number79213430
Word MarkQSELEQ
Filing DateThursday, April 27, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 21, 2024
Registration Number5348384
Registration DateTuesday, December 5, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Thursday, August 3, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, August 8, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, August 30, 2017NOTICE OF PUBLICATION
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, January 4, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Saturday, January 20, 2018FINAL DISPOSITION PROCESSED
Friday, August 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 4, 2017ASSIGNED TO EXAMINER
Sunday, August 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 9, 2018NOTIFICATION PROCESSED BY IB
Friday, June 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 20, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 5, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 21, 2024CANCELLED SECTION 71
Friday, February 21, 2025TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, June 19, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 9, 2025INVALIDATION PROCESSED
Saturday, May 10, 2025TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, May 31, 2025TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

qseleq human vaccines